多组学与空间生物学在肝细胞癌中的研究启示
本文综述空间转录组学、蛋白组学、基因组学、表观组学和代谢组学在肝细胞癌中的应用,阐明肿瘤微环境的空间组织如何影响进展、免疫逃逸和治疗反应,并探讨空间特征用于风险分层、治疗选择和临床试验设计的转化前景。
要点
- 空间组学可在保留组织架构下进行分子 profiling,揭示细胞邻域、免疫屏障和基质 niche 对肿瘤行为的塑造。
- 空间分辨分析发现侵袭边缘、巨噬细胞和成纤维细胞 niche 及免疫逃逸的空间动态,并识别预后和预测生物标志物。
- 空间映射的配体-受体网络揭示定义微环境中可靶向耐药和进展机制的协调信号回路。
核心结论
- 空间组学将空间架构与分子功能整合,正在改变对肝癌生物学的理解,并为空间信息指导的精准肿瘤学铺路。
研究设计与样本
- 综述,总结空间转录组学、蛋白组学、基因组学、表观组学和代谢组学在肝细胞癌中的应用进展。
主要发现
- 空间组学技术可在完整组织架构内进行分子 profiling,揭示细胞邻域、免疫屏障和基质 niche 如何塑造肿瘤行为。
- 空间分辨分析阐明侵袭边缘、巨噬细胞和成纤维细胞 niche 及免疫逃逸的空间动态,识别预后和预测生物标志物。
- 空间映射的配体-受体网络揭示定义微环境中可靶向耐药和进展机制的协调信号回路。
临床怎么用
- 空间特征可能指导风险分层、治疗选择和临床试验设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatocellular carcinoma (HCC) is a biologically and clinically heterogeneous cancer in which the spatial organization of the tumor microenvironment dictates progression, immune escape, and therapeutic response. Traditional genomic and transcriptomic profiling have revealed key molecular pathways, yet they do not capture the spatial relationships that govern tumor-immune-stromal interactions. Spatial omics technologies now bridge this gap, allowing molecular profiling within intact tissue architecture and revealing how cellular neighborhoods, immune barriers, and stromal niches shape tumor behavior. In this review, we summarize recent advances in technologies like spatial transcriptomics, proteomics, genomics, epigenomics, and metabolomics as applied to HCC. We discuss how these technologies have illuminated the spatial dynamics of the invasive margin, macrophage and fibroblast niches, and immune evasion, identifying both prognostic and predictive biomarkers. We further highlight how spatially resolved analyses have uncovered previously unrecognized axes of communication between cancer cells and key stromal and parenchymal populations that were not apparent from bulk or single-cell molecular analyses alone. These spatially mapped ligand-receptor networks reveal coordinated signaling circuits that define targetable mechanisms of resistance and progression within the microenvironment. Finally, we explore the translational implications where spatial signatures may guide risk stratification, treatment selection, and clinical trial design. By integrating spatial architecture with molecular function, spatial omics is transforming our understanding of liver cancer biology and paving the way for spatially informed precision oncology.
引用
- Massoudi D, Srivastava A, Dhanasekaran R, et al. Unraveling the tapestry: Lessons from multi-omics and spatial biology in hepatocellular cancer. Hepatology. 2026. PMID: 41678777. doi:10.1097/HEP.0000000000001716
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。